An individual who suffers from both mental illness and alcoholism will need to undergo different treatment. Because alcohol withdrawal symptoms cause a person to experience some psychiatric stress, an alcoholic with mental health issues will find it much more difficult to resist turning to drink. The NIAAA believes the some self-help groups, such as Alcoholics Anonymous, are not effective when it comes to treating people with a dual-diagnosis of both alcoholism and mental illness. This is because these groups tend to specifically focus on the actual addiction itself, rather than any underlying psychological problems. Anti-depressants are improving all the time and it is believed that while a self-help group may not be useful for a dual-diagnosis individual by itself, if the individual is on the appropriate medication and receiving the appropriate psychological therapy it can prove to be just as effective as with other alcoholic individuals.
Withdrawal is medically supervised and supported by our on-site nurses. For certain cases, we make use of medical aids to render the process much easier and safer. For opiate withdrawals we use suboxone, and for Benzodiazepine withdrawal we follow a modified version of the Ashton protocol. Alcohol withdrawal is medically supervised and medication is given to eliminate the risk of seizure and stroke. We take every measure to ensure that this first, important stage towards drug addiction recovery is a comfortable and safe one. To find out more about the detox program at Searidge please call us at 1-866-777-9614.
Changes in the brain that support physical and psychological dependency on mind-altering substances are the direct cause of addiction, but those changes do not occur at random. Addiction experts believe drug addiction emerges from an interplay of genetic and environmental factors, although one factor or the other may be strong enough to make a person vulnerable to addiction in some instances. Best Drug Rehabilitation Manistee, MI 855-995-3815
In the 2014 National Survey on Drug Use and Health (NSDUH), 20.2 million American adults reported a past-year substance use disorder, and out of this group 7.9 million (39.1 percent) also suffered from a co-occurring mental health disorder. The range of co-occurring disorders known to coincide with drug addiction is broad and includes virtually every type of mental illness recognized by the American Psychiatric Association.
A few antidepressants have been proven to be helpful in the context of smoking cessation/nicotine addiction, these medications include bupropion and nortriptyline. Bupropion inhibits the re-uptake of nor-epinephrine and dopamine and has been FDA approved for smoking cessation, while nortriptyline is a tricyclic antidepressant which has been used to aid in smoking cessation it has not been FDA approved for this indication.
^ "Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th edition)2014 102 Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th edition) Washington, DC American Psychiatric Association 2013 xliv+947 pp. 9780890425541(hbck);9780890425558(pbck) £175 $199 (hbck); £45 $69 (pbck)". Reference Reviews. 28 (3): 36–37. 2014-03-11. doi:10.1108/rr-10-2013-0256. ISSN 0950-4125.
Addiction comes in many forms and is largely found to involve more than one substance or condition. One of the more common coexisting substance combinations is alcohol and drug addiction. According to The National Council on Alcoholism and Drug Dependence, more than 23 million people over the age of 12 are faced with an addiction to both alcohol and drugs. Many substance abuse treatment centers address both substances. The individualized programs at The Recovery Village focus on treating addiction to drugs, alcohol, or both, in addition to co-occurring mental disorders.
Even relatively moderate drug use poses dangers. Consider how a social drinker can become intoxicated, get behind the wheel of a car, and quickly turn a pleasurable activity into a tragedy that affects many lives. Occasional drug use, such as misusing an opioid to get high, can have similarly disastrous effects, including overdose, and dangerously impaired driving.
Within the framework of the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), substance dependence is redefined as a drug addiction, and can be diagnosed without the occurrence of a withdrawal syndrome. It was described accordingly: "When an individual persists in use of alcohol or other drugs despite problems related to use of the substance, substance dependence may be diagnosed. Compulsive and repetitive use may result in tolerance to the effect of the drug and withdrawal symptoms when use is reduced or stopped. This, along with Substance Abuse are considered Substance Use Disorders." In the DSM-5 (released in 2013), substance abuse and substance dependence have been merged into the category of substance use disorders and they no longer exist as individual diagnosis.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)